Tanenbaum Keale partner Dennis Vega will be a panelist for a CLE session during next week’s 2021 Hispanic National Bar Association (HNBA)/Vision in Action (VIA) Annual Convention, a hybrid virtual/in-person three-day event. He will be discussing “Lasting Litigation Trends of COVID-19 with attorneys Joseph L. Linares and Mayling C. Blanco, the Hon. Judge Zahid N. Quraishi and general counsel Miguel A. Pozo on Tuesday, September 28.
Members of the panel will look at the current litigation landscape as a result of COVID-19, what the pandemic has taught legal professionals about case management and the practice of law, and what changes expect to last in local and federal litigation. This will include takeaways from virtual trials, hearings and depositions and what expectations have changed for litigants.
The HNBA/VIA Conference offers high-quality educational programming for legal professionals at all levels that includes cutting-edge CLEs, plenaries and specialty programs, along with an exhibitor showcase and multiple unique networking opportunities.
Founded in 1972, the HNBA is a national membership association that represents the interests of over 65,000 Hispanic attorneys, judges, law professors, legal assistants, law students and legal professionals in the United States and its territories. The organization continues to influence positive change within the legal profession by creating opportunities for Hispanic lawyers and effectively advocating on issues of importance to the national Hispanic community.
VIA is the charitable arm of the HNBA.
At TK, Vega focuses his practice in areas of product liability, asbestos, environmental and toxic tort, and healthcare litigation. He is an experienced litigation and trial attorney who has served as national, regional or local counsel for various global industrial equipment manufacturers, distributors and contractors in the power, oil, chemical, railroad and automotive industries. He also counsels corporate clients and scientists on selecting products suitable for laboratory testing to develop sophisticated exposure modeling for litigation and trial purposes.